antiasthmatic/inflammation

The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs. Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of

The invention relates to the potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs. Despite the fact that more refined drugs are available and that asthma care is better overall, nevertheless the mortality and morbidity of

BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to 1-[(3- or 4-benzoylphenyl)-lower-alkyl]-[(CH.sub.2).sub.n --N.dbd.B]-substituted-piperidines and analogs thereof, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents;

TECHNICAL FIELD The invention relates to the preparation and use of novel derivatives of indazol-3-ol as medicaments having anti-asthmatic, anti-allergic, anti-inflammatory, immuno-nodulating and neuroprotective properties. PRIOR ART Cyclosporin A (CsA) or FK 506 are immunosuppressant natural

TECHNICAL FIELD The present invention relates to a novel agent or composition for use as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction (human stroke

BACKGROUND OF THE INVENTION EP 419,049, Prasit et al., Mar. 27, 1991, describes a series of quinolin-2-ylmethoxy indoles useful as inhibitors of leukotriene biosynthesis. Examples 1 and 1A therein teach the synthesis of 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-

This invention relates to heterocyclic compounds and their preparation and to the use of such compounds of pharmaceutical formulations thereof in medicine in a mammal, including man, as e.g. anti-inflammatory or anti-allergic agents or as agents in the prevention of tissue rejection. Accordingly,

TECHNICAL FIELD The present invention relates to a composition comprising an extract of Tiarella polyphylla and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome occurring in the

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a 371 of PCT/KR2006/002092 filed on May 30, 2006, which claims the benefit of Korean Patent Application Nos. 10-2005-0045755 filed on May 30, 2005, 10-2005-0045756 filed on May 30, 2005, 10-2006-0048104 filed on May 29, 2006 and

TECHNICAL FIELD The present invention relates to a composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome

TECHNICAL FIELD The present invention relates to a composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. BACKGROUND ART Asthma has been regarded as a complex syndrome

FIELD OF INVENTION This invention relates to folic acid antagonists that are metabolically inert exhibiting a high level of anti-inflammatory and anti-tumor activity. Metabolically inert classical antifolates are new and therefore they exhibit unexpected biological properties such as those recited

The present invention relates to [3H, 7H]thiazolo[3,4-a]-pyridines, a method for preparing them and pharmaceutical compositions which contain them. More precisely the invention relates to compounds of formula (I) ##STR2## in which: R is (C.sub.1 -C.sub.4) alkyl; R.sub.1 is a cyano, free or salified

TECHNICAL FIELD The present invention relates to novel N-hydroxyurea derivative having a lipoxygenase inhibitory activity and a thromboxane synthase inhibitory activity and pharmaceutical composition containing the same. BACKGROUND ART In recent years, the role of chemical mediators in asthma and

BACKGROUND OF THE INVENTION The leukotrienes and their biological activities, especially their role in various disease states, have been extensively studied. Their properties are described in the book Leukotrienes and Lipoxygenases, Ed., J. Rokach, Elsevier, N.Y., 1989. Inhibitors of the